- Research works
- 68 ▲ 225% vs 2013–17
- Citations
- 1.1k 15.7 per fractional work
- Top-10% rate
- 14.7% record average 16.5%
- Open access
- 52% world 28%
Not ranked overall: Sanofi (India) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 13.3×. Every wedge is a field page.
- Veterinary 13.3×
- Pharmacology, Toxicology and Pharmaceutics 11.0×
- Decision Sciences 7.5×
- Mathematics 7.3×
- Immunology and Microbiology 4.8×
- Medicine 2.5×
- Economics, Econometrics and Finance 2.2×
- Chemistry 2.1×
- Dentistry 1.9×
- Health Professions 1.7×
- Biochemistry, Genetics and Molecular Biology 1.5×
- Nursing 0.9×
- Computer Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Social Sciences 0.0×
Which keywords describe research at Sanofi (India)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Glycemic Control, Pathogenesis, Insulin Therapy, Clinical Guidelines, Cardiovascular Disease, Diabetes and Immunity.
- Ground Motion
- Anesthesia
- Mucosal
- Glucose Control
- Cardiovascular Outcomes
- Pharmaceutical Industry
- Health Utility Measures
- Cost-effectiveness Analysis
- Economic Evaluation
- Quality Assessment
- Global Burden
- Hypoglycemia
- Heart Failure
- Vaccine
- Type 1 Diabetes
- Clinical Trials
- Diabetes
- Clinical Guidelines
- Insulin Therapy
- Cardiovascular Disease
- Epidemiology
- Glycemic Control
- Pathogenesis
- Inflammation
- Quality of Life
- Immunity
- Complications
- Genetics
- Continuous Glucose Monitoring
- Drug Delivery
- Pharmacokinetics
- Adverse Drug Reactions
- Publication Bias
- Diabetes Mellitus
- Nasal
- Type 2 Diabetes
- Chitosan
- Molecular Mechanisms
- Treatment Guidelines
- Diagrid Structures
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology9▲ 3.1×31 topics
- Cardiovascular Disease4▲ 5.0×6 topics
- Glycemic Control4▲ 41×4 topics
- Insulin Therapy4▲ 49×3 topics
- Pathogenesis4▲ 9.8×12 topics
- Clinical Guidelines3▲ 15×5 topics
- Inflammation3▲ 1.95×14 topics
- Diabetes3▲ 8.7×6 topics
- Quality of Life3▲ 3.0×7 topics
- Clinical Trials3▲ 6.4×8 topics
- Immunity2▲ 11×4 topics
- Type 1 Diabetes2▲ 40×2 topics
- Complications2▲ 6.5×4 topics
- Vaccine2▲ 8.1×8 topics
- Genetics2▲ 4.0×9 topics
- Heart Failure2▲ 6.7×5 topics
- Continuous Glucose Monitoring2▲ 64×1 topic
- Hypoglycemia2▲ 64×1 topic
- Drug Delivery2▲ 5.5×4 topics
- Global Burden2▲ 4.8×6 topics
- Pharmacokinetics2▲ 9.8×5 topics
- Quality Assessment2▲ 14×3 topics
- Adverse Drug Reactions2▲ 39×2 topics
- Economic Evaluation2▲ 19×2 topics
- Publication Bias2▲ 46×2 topics
- Cost-effectiveness Analysis2▲ 31×1 topic
- Diabetes Mellitus2▲ 10×4 topics
- Health Utility Measures2▲ 31×1 topic
- Nasal2▲ 46×2 topics
- Pharmaceutical Industry2▲ 57×2 topics
- Type 2 Diabetes2▲ 12×3 topics
- Cardiovascular Outcomes1▲ 48×1 topic
- Chitosan1▲ 38×1 topic
- Glucose Control1▲ 48×1 topic
- Molecular Mechanisms1▲ 11×2 topics
- Mucosal1▲ 76×1 topic
- Treatment Guidelines1▲ 9.6×4 topics
- Anesthesia1▲ 17×3 topics
- Diagrid Structures1▲ 416×1 topic
- Ground Motion1▲ 67×1 topic
Which research topics does Sanofi (India) publish most on?
By volume in 2022–2025: Meta-analysis and systematic reviews, Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life and Multiple Myeloma Research and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Meta-analysis and systematic reviews Statistics, Probability and Uncertainty 1 works
- 2 Statistical Methods in Clinical Trials Statistics and Probability 1 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 4 Multiple Myeloma Research and Treatments Hematology 0 works
- 5 Advanced Statistical Methods and Models Statistics and Probability 0 works
- 6 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 7 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 8 Diabetes and associated disorders Genetics 0 works
- 9 Protein purification and stability Molecular Biology 0 works
- 10 Adipose Tissue and Metabolism Physiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sanofi (India)'s research output changed?
Output in 2018–2022 was 225% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mumbai
- Indian Institute of Technology Bombay
- Bhabha Atomic Research Centre
- Tata Institute of Fundamental Research
- University of Mumbai
- Institute of Chemical Technology
- Homi Bhabha National Institute
- Tata Memorial Hospital
- Narsee Monjee Institute of Management Studies
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.